| |
| |
|
| Insider
Information: |
Colella Samuel D |
| Relationship: |
Director |
| City: |
Santa Clara |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
203,276 |
|
|
Indirect Shares
|
2,453,199 |
|
|
| Direct
Value |
$697,433 |
|
|
|
Indirect Value
|
$21,027,073 |
|
|
| Total
Shares |
2,656,475 |
|
|
| Total
Value |
$21,724,506 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 130.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genomic Health Inc |
GHDX |
Director |
2014-10-01 |
5,305 |
2014-10-01 |
54,348 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2010-01-26 |
36,862 |
2010-01-26 |
2,183,128 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2006-05-15 |
13,713 |
Premium* |
|
|
Insulet Corp |
PODD |
Former 10% Owner |
2007-05-14 |
0 |
2007-05-14 |
89,372 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2007-06-06 |
0 |
2008-07-21 |
13,247 |
Premium* |
|
|
Fluidigm Corp |
FLDM |
Director |
2020-03-11 |
161,109 |
2020-03-11 |
78,159 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
Director, 10% Owner |
2013-11-04 |
0 |
2013-11-04 |
21,232 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Director |
2021-11-19 |
0 |
2021-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GHDX |
Genomic Health Inc |
Director |
– • – |
2005-10-04 |
4 |
A |
$0.00 |
$0 |
I/I |
92,008 |
2,192,150 |
|
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2005-10-04 |
4 |
A |
$0.00 |
$0 |
I/I |
2,274,612 |
2,106,923 |
|
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Director |
– • – |
2006-03-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,183,128 |
10,440 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,843,899 |
13,713 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-15 |
4 |
B |
$0.00 |
$0 |
I/I |
230,769 |
2,044,744 |
1.42 |
- |
|
| PODD |
Insulet Corp |
Former 10% Owner |
– – – |
2007-05-14 |
4 |
A |
$0.00 |
$0 |
I/I |
2,127,943 |
89,372 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2007-06-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,234,161 |
1,234,161 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2008-07-21 |
4 |
B |
$0.00 |
$0 |
I/I |
296,022 |
13,247 |
2.02 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Director |
– • – |
2009-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
16,904 |
16,904 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Director |
– • – |
2010-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
19,958 |
36,862 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2010-03-09 |
4 |
S |
$19.63 |
$1,177,800 |
I/I |
(60,000) |
86,808 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2010-03-10 |
4 |
S |
$19.21 |
$897,107 |
I/I |
(46,700) |
85,050 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2010-12-10 |
4 |
A |
$0.00 |
$0 |
I/I |
13,430 |
9,004 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2010-12-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(550,000) |
61,301 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2011-02-15 |
4 |
A |
$0.00 |
$0 |
I/I |
81,581 |
81,581 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2011-02-15 |
4 |
A |
$0.00 |
$165 |
I/I |
969,359 |
1,050,940 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2011-02-15 |
4 |
OE |
$0.02 |
$165 |
I/I |
8,247 |
1,059,197 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2011-02-15 |
4 |
D |
$13.50 |
$149 |
I/I |
(11) |
1,059,186 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2011-03-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(515,680) |
20,838 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
I/I |
13,053 |
17,757 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2011-03-03 |
4 |
S |
$25.45 |
$873,444 |
I/I |
(34,320) |
37,552 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2011-04-01 |
4 |
A |
$24.60 |
$9,988 |
D/D |
406 |
406 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2011-07-01 |
4 |
A |
$27.91 |
$9,992 |
D/D |
358 |
764 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-01-01 |
4 |
A |
$25.39 |
$9,978 |
D/D |
393 |
1,611 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-04-01 |
4 |
A |
$30.61 |
$9,979 |
D/D |
326 |
1,937 |
0 |
- |
|
105 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
